Molecular Diagnostics Market: Analyzing the Impact of Emerging Technologies

 The global molecular diagnostics market size is expected to reach USD 17.97 billion by 2030, and expanding at a CAGR of 4.5% from 2024 to 2030, according to a recent study by Grand View Research, Inc. The contraction in the market will be due to the decline in demand for molecular testing for COVID-19. However, factors such as the rising geriatric population and increasing demand for technologies such as NGS is expected to drive market growth.

 

Molecular diagnostics plays an important role in infectious disease testing as they can yield effective and fast results. Hence, the increasing prevalence of hospital-acquired infections & infectious diseases is projected to drive the market over the forecast period. Increasing incidence and awareness regarding genetic disorders is further anticipated to accelerate market growth. The miniaturization of three basic molecular assays-nanobiotechnology, biochips, and microfluidics are expected to increase the accuracy and specificity of diagnostic outcomes, and hence, increase the demand for molecular diagnostic products. These improvements are expected to enhance the availability of PoC molecular diagnostic tests to yield quick and effective test results.

 

Gather more insights about the market drivers, restrains and growth of the Global Molecular Diagnostics Market

 

Companies are expanding their product portfolios with the acquisition of smaller companies. For instance, in March 2021, Hologic announced the acquisition of Diagenode-a molecular diagnostic company with a wide range of PCR instruments, facilitating the detection of over 30 bacteria-for USD 159 million. Similarly, in April 2021, F. Hoffmann-La Roche Ltd. acquired GenMark Diagnostics, Inc. at a price of USD 24.05 per share in cash, and it holds around 82.89% of total shares of GenMark Diagnostics. GenMark Diagnostics, Inc. has proprietary technologies, such as eSensor XT-8 and ePlex, which can be utilized in developing tests for infectious diseases, including bloodstream infections.

 

Key players are enhancing their range of testing options for real-time PCR instruments by increasing R&D activities for the development of kits that target emerging diseases or by entering into agreements with other kit manufacturing companies. These include the introduction of Cobas HPV test assay in Cobas 4800 by Roche Diagnostics. The introduction of tuberculosis testing Xpert assay on GeneXpert platform by Cepheid is an example of such advancement. Such advances are anticipated to drive the global molecular diagnostics market.

 

Molecular Diagnostics Market Segments Highlights:

 

• The reagents segment dominated the market and accounted for a share of 62.2% of the global revenue in 2023. It is expected to maintain its dominance throughout the forecast years owing to its wide application scope in research & clinical settings and increasing adoption of novel tests.

• The polymerase chain reaction technology segment accounted for the largest revenue share in 2023. This is attributed to its use in detecting COVID-19 and other infectious diseases.

• The infectious diseases segment accounted for the largest revenue share in 2023. The increased usage of molecular, particularly PCR tests, for diagnosing COVID-19 has increased the segment share significantly.

• The central laboratories segment dominated the industry in 2023 owing to high procedure volumes for COVID testing and other healthcare indications in central laboratories.

• North America dominated the market and accounted for a 39.3% share in 2023. This is attributed to the rising epidemiology of infectious as well as chronic diseases, thus, encouraging companies to introduce novel molecular diagnostic tests, thereby boosting market growth.

• Asia Pacific is anticipated to exhibit significant growth from 2024 to 2030 owing to increased market penetration, initiatives of local market players to increase the adoption of novel diagnostic technologies, and high unmet market needs.

 

Order a free sample PDF of the Molecular Diagnostics Market Intelligence Study, published by Grand View Research.

 

Digital Therapeutics Market: Transforming Healthcare Delivery

 The global digital therapeutics market size is expected to reach USD 32.52 billion by 2030, exhibiting a CAGR of 27.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The primary driver for expanding the market growth is the increased use of smartphones. The affordability of digital health technologies for healthcare providers & patients, rising demand for integrated healthcare systems, and care focusing on the patient are key factors fueling the market's growth. Furthermore, the growing globalization and shifts in lifestyle habits, such as higher rates of tobacco use, inadequate nutrition, insufficient physical activity, and rising alcohol consumption, increase the likelihood of chronic disease development.

 

Gather more insights about the market drivers, restrains and growth of the Global Digital Therapeutics Market

 

The market’s expansion is significantly influenced by the increasing adoption of digital therapeutics and the supportive initiatives by leading regulatory agencies such as the FDA. For instance, the U.S. FDA provided guidelines in April 2020 to enhance the reach of digital therapeutic devices for people suffering from psychiatric disorders. Furthermore, according to Kepios data, there's a 7.6% annual growth rate in the global internet user base, translating to around 900,000 new internet users daily. While developed and developing nations boast high smartphone and internet usage levels, areas such as Africa and South Asia need to catch up due to their economic limitations.

 

Increasing prevalence of chronic diseases is also driving the growth of the market. As per the CDC’s National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 American adults suffer from a chronic disease, while 4 out of 10 adults have two or more chronic diseases. For instance, in February 2022, Teladoc Health, Inc. launched Chronic Care Complete, a chronic condition management solution to improve healthcare outcomes. Cardiovascular diseases, cancer, diabetes, chronic kidney disease, chronic lung disease, and Alzheimer’s have been identified as the leading causes of death and disability in the country.

 

Digital Therapeutics Market Report Highlights

 

• Based on application, diabetes held a market share of 29.36% in 2023, owing to rapid technological advancements by market players in the segment. The segment is also expected to witness the fastest growth over the forecast period

• The patients segment held the largest market share of 34.08% in 2023, owing to the growing number of patients suffering from chronic conditions. Digital therapeutics can also help improve access to care for people, especially those from rural and remote areas

• North America dominated the global market in 2023 owing to the high demand for digital therapeutics in the region. These regional marketplaces are expected to show similar trends throughout the forecast period due to rising healthcare awareness coupled with increased use of digital health products over the forecast period

Browse through Grand View Research's Healthcare IT Industry Research Reports.

• The global healthcare application lifecycle management solutions market size was estimated at USD 630.8 million in 2023 and is projected to grow at a CAGR of 6.7% from 2024 to 2030.

• The India clinical trials market is valued at USD 1.42 billion in 2024 and is expected to grow at a CAGR of 8.0% from 2025 to 2030, driven by the expanding pharmaceutical and biotechnology sectors.

 

Segments Covered in the Report

 

Grand View Research has segmented the global digital therapeutics market based on application, end user, and region:

 

Digital Therapeutics Application Outlook (Revenue, USD Million, 2018 - 2030)

• Diabetes

• Obesity

• CVD

• Respiratory Diseases

• Smoking Cessation

• CNS Diseases

• Others

 

Digital Therapeutics End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Patients

• Providers

• Payers

• Employers

• Others

 

Digital Therapeutics Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

 

Order a free sample PDF of the Digital Therapeutics Market Intelligence Study, published by Grand View Research.

 

Advanced Wound Care Market: Future Directions and Research Opportunities

 The global advanced wound care market size is expected to reach USD 14.87 billion by 2030, expanding at a CAGR of 4.75% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growth in the number of the aging population as well as an increasing figure of diabetic patients are some major factors driving this market’s growth.

 

For instance, as per a United Health Foundation report (published in May 2023), more than 55.8 million adults aged 65 and older lived in the U.S., accounting for about 16.8% of the nation's population in 2021, increasing the number of senior populations is anticipated to propel the market during the forecast period.

 

Gather more insights about the market drivers, restrains and growth of the Global Advanced Wound Care Market

 

There has been growth in the number of surgical procedures, and traumatic incidents globally. For instance, as per a study by Research Gate, in 2022, around 6.6% of mortality occurs due to trauma every year. Similarly, there has been an increase in the number of surgical site infections. Advanced wound care products help to contain and reduce these surgical site infections, thereby, an increase in the number of surgical site infections is expected to drive the market during the forecast period.

The introduction of the COVID-19 vaccine, and the lifting of lockdown impositions, are expected to have a positive impact on the market over the forecast period. Many elective surgeries, which were postponed, are expected to take place. In addition to this, many leading manufacturers are introducing new products which may help them to capitalize on the increasing demand for advanced wound care products during the forecast period.

 

Advanced Wound Care Market Report Highlights

• Based on product, the moist wound care segment led the market with the largest revenue share of 70.88% in 2023. This dominance can be attributed to an increase in a number of wound cases and increase in number of surgeries globally.

• In terms of application, the chronic wounds segment is dominate the market with the largest revenue share in 2023. Increasing number of diabetic foot ulcers, venous pressure ulcers, and other chronic wounds is expected to drive the segment growth.

• Based on end-use, the hospital segment held the market with the largest revenue share of 45.31% in 2023. The growth of this segment can be attributed to the upsurge in surgical procedures and increase in the number of hospital admissions.

• North America dominated the market with the revenue share of 45.46% in 2023. This dominance can be attributed to well-developed healthcare infrastructure and increase in the number of surgical procedures.

• Asia Pacific is anticipated to witness significant CAGR during the forecast period. This can be attributed to the presence of major key players, the increasing prevalence of chronic disorders, and rising healthcare expenditure.

 

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global dental protein combined products market size was estimated at USD 1.02 billion in 2024 and is projected to grow at a CAGR of 10.0% from 2025 to 2030.

• The global wearable artificial kidney market size was valued at USD 575.5 million in 2024 and is anticipated to grow at a CAGR of 6.9% from 2025 to 2030.

 

Segments Covered in the Report

 

Grand View Research has segmented the global advanced wound care market based on product, application, end use, and region:

 

Advanced Wound Care Product Outlook (Revenue, USD Million, 2018 - 2030)

• Moist

  • Foam Dressings

  • Hydrocolloid Dressings

  • Film Dressings

  • Alginate Dressings

  • Hydrogel Dressings

  • Collagen Dressings

  • Other Advanced Dressings

• Antimicrobial

  • Silver

  • Non-silver

• Active

  • Biomaterials

  • Skin-substitute

  • Growth Factors

 

Advanced Wound Care Application Outlook (Revenue, USD Million, 2018 - 2030)

• Chronic Wounds

  • Diabetic Foot Ulcers

  • Pressure Ulcers

  • Venous Leg Ulcers

  • Other Chronic Wounds

• Acute Wounds

  • Surgical & Traumatic Wounds

  • Burns

 

Advanced Wound Care End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Specialty Clinics

• Home Healthcare

• Others

 

Advanced Wound Care Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

 

Order a free sample PDF of the Advanced Wound Care Market Intelligence Study, published by Grand View Research.